Background {#Sec1}
==========

Although numerous studies on total shoulder arthroplasty (TSA) have aimed to find the optimal TSA design, no definite conclusions have been made \[[@CR1]\]. The glenoid component of TSA is divided into keel type and peg type according to its shape, and can be made of all polyethylene (PE) or be metal-backed. Both metal-backed glenoids (MBG) and cemented polyethylene glenoids (PEG) were initially used, however due to the nature of the initial MBG design, the polyethylene liner was very thin and resulted in a high wear and failure rate \[[@CR2]\]. A systematic review conducted in 2014 concluded that MBGs are not recommended as they show higher failure rates \[[@CR3]\].

However, advanced MBG designs were devised to address these shortcomings, increasing the chance of good clinical outcomes \[[@CR4]--[@CR6]\]. We aimed to summarize and compare the results of TSA using cemented PEG and modern MBG by examining radiolucency, loosening, and failure rate. Our null hypothesis was that radiolucency, loosening, and failure rates of modern MBGs would be similar to those of cemented PEG.

Methods {#Sec2}
=======

This systematic review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines \[[@CR7]\]. Additionally, we have registered the current review on the website of International prospective register of systematic reviews (PROSPERO, CRD42019137134).

Inclusion and exclusion criteria {#Sec3}
--------------------------------

We regulated various factors that could cause heterogeneity using strict inclusion and exclusion criteria determined by group discussion. Articles eligible for inclusion had to be a study on adults (\> 18 years old), be a clinical study presenting the results of TSA using the cemented PEG or modern MBG with more than a 2 year mean follow-up (FU), a study including any type of shoulder arthritis, and be written in English. Case reports or articles with fewer than 5 cases were excluded. Also, articles that show the results of hybrid cage glenoids, mixed cases of revision arthroplasty, or mixed cases of structural bone graft, and articles which do not present the main outcomes (number of revisions or failure) were excluded.

Search strategy and study selection {#Sec4}
-----------------------------------

PubMed, Embase, Google Scholar, and Cochrane Library were searched to find a large number of relevant articles. We conducted group discussions and consulted medical informatics experts for an effective search strategy. After such discussions and consultations, we decided to search for final articles using individual search terms for MBG and PEG, respectively. The search terms for articles on cemented PEG were "total AND shoulder AND (replacement OR arthroplasty) AND polyethylene". Search terms for articles on modern MBG were "total AND shoulder AND (replacement OR arthroplasty) AND (metal OR backed OR (cementless glenoid))". After excluding duplicated documents, two independent reviewers screened the title and abstract, and finally selected articles through full-text review. We also performed citation tracking and search updates to find additional related articles using Google Scholar as an additional tool. All disagreements were resolved through group discussions of three or more authors.

Methodological assessment and data extraction {#Sec5}
---------------------------------------------

Levels of evidence were assessed according to the Oxford Center for Evidence Based Medicine \[[@CR8]\]. The methodological quality of the studies included in this review was assessed using the methodological index for non-randomized studies (MINORS) \[[@CR9]\]. A total of 8 items were evaluated for non-comparative studies, and 12 items for comparative studies. As 0, 1, or 2 points can be assigned to each item, non-comparative studies can have a total of 16 points, while comparative studies can have a total of 24 points. A study that obtained more than 60% of the total score was considered as a high-quality article, and the distribution of high-quality articles was analyzed between the two groups.

In order to define "modern design", the core topic of this study, the most up to date articles on the glenoid component were reviewed in group discussion. The advanced MBG designs presented by Castagna and Garofalo, who comprehensively assessed the product development year, conformity, rod, keel shape, and material, were defined as modern MBGs \[[@CR10]\]. We included three designs in the modern MBG group: 1) second-generation SMR MBG (SMR System, Lima Corporate, Villanova, di San Daniele, Udine, Italy), 2) first-generation trabecular metal (TM) glenoid which consists of a soft MBG, the Sulmesh (Zimmer, Winterthur, Switzerland), and 3) the second-generation TM glenoid (Zimmer, Winterthur, Switzerland). If studies on the recent MBG design (after 2010) which was not one of the three designs mentioned above were found, we decided to conduct a group discussion. No such study was found, so the three designs were finally considered "modern design".

Three independent reviewers extracted the number of shoulders, age, sex, FU duration, surgery procedures, medical and surgical history, preoperative diagnosis, name of implant and manufacturer, clinical score, range of motion (ROM), radiologic FU such as radiolucent lines, loosening, other complications, and revision or failure from the articles. The radiolucent line was defined as a radiolucency of 1 mm or more, grade 2 or more on the Lazarus radiolucency scoring system, or seven or more points out of a total of 18 points \[[@CR11]\]. Failure was defined as complications that resulted in revision surgery involving an implant-related procedure. Loosening included both radiological and clinical loosening. Data presented by other methods and ambiguous data were not extracted.

Statistical analyses {#Sec6}
--------------------

We used strict criteria to minimize heterogeneity. However, trends in age, FU duration, and preoperative diagnosis could be identified after data extraction. In particular, FU duration was considered to be the most important variable associated with implant failure. We collaborated with medical statisticians on data interpretation and data analysis (including scatter plot and subgroup analysis). For categorical variables such as the presence of radiolucent lines, loosening, and failure or revision surgeries, statistical analysis was performed on the difference between cemented PEG and modern MBG.

Since the FU duration varies from study to study, we determined that a simple overall comparison between 2 groups was not sufficient, and therefore two additional analyses were performed according to the FU duration. Firstly, a scatter plot was used that plots the mean FU duration and loosening and revision rates of each study. Trend lines were weighted according to the number of cases to identify trends of loosening and revision rates between the two groups. Secondly, a subgroup analysis was performed that divided the FU duration into three groups based on 36 and 72 months as the statistician suggested. Articles were divided into 3 groups based on follow-up duration: \< 36-month, 36--72-month, and \> 72-month subgroups. Subsequently, we analyzed the radiolucency, loosening, and revision rates overall, and for the \< 36-month, 36--72-month, and \> 72-month subgroups. All statistical analyses were performed using R version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria). *P*-values less than 0.05 were determined to be statistically significant. Since numerical data were often missing important values such as standard deviation, a meta-analysis could not be performed. Therefore, descriptive analysis and weighted means were performed on the numerical data of 2 groups.

Results {#Sec7}
=======

Search results {#Sec8}
--------------

Two hundred forty-one articles on cemented PEG were found in PubMed, 371 in Embase, and 24 articles in Cochrane Library. Subsequently, 177 articles on modern MBG were found in PubMed, 324 articles in Embase, and 29 articles in Cochrane Library. Through screening titles and abstracts and using full-text review, 25 PEG and 9 MBG articles were included. One article was added through citation tracking of selected articles, and no additional articles were found in the search update (Fig. [1](#Fig1){ref-type="fig"}). The final cemented PEG group included 3312 patients (25 articles) \[[@CR12]--[@CR36]\], and the modern MBG group included 457 patients (10 articles) \[[@CR4]--[@CR6], [@CR37]--[@CR43]\]. Fig. 1PRISMA flow diagram showing the selection of appropriate articles

Assessment of methodological quality and heterogeneity between two groups {#Sec9}
-------------------------------------------------------------------------

Levels of evidence and MINORS scores were determined by agreement between the two investigators, and there was no disagreement; one randomized controlled trial (Level I), one prospective comparative study (Level II), five Level III studies, and 28 Level IV studies were included. The mean MINORS scores, except for one Level I study, were 9.75 ± 1.38 for non-comparative studies and 16.8 ± 1.57 for comparative studies. Fifteen of the 25 studies on the cemented PEG (including Level I study, 60%) and 6 of the ten studies on the modern MBG (60%) were classified as high-quality articles (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2"Methodological index for non-randomized studies" scores of individual articles and the range that indicates high-quality articles. PEG, polyethylene glenoid; MBG, metal-backed glenoid

We analyzed the distribution of three factors that could introduce heterogeneity. Age and FU duration are shown using the summary plot (Fig. [3](#Fig3){ref-type="fig"}a and b). Age showed a similar pattern except for three studies in the PEG group with young adults, whereas the cemented PEG group tended to have a longer FU period than the modern MBG group. The distribution of preoperative diagnosis was similar between the two groups (Fig. [4](#Fig4){ref-type="fig"}), and the proportion of primary osteoarthritis was not statistically different (*P* = 0.310). Fig. 3(**a**) Summary plots for age (**b**) Summary plots for follow-up duration. PEG, polyethylene glenoid; MBG, metal-backed glenoid Fig. 4Graph showing the distribution of preoperative diagnosis for each group. PEG, polyethylene glenoid; MBG, metal-backed glenoid; OA, osteoarthritis

Summary of outcomes of each article {#Sec10}
-----------------------------------

Table [1](#Tab1){ref-type="table"} shows the demographic data and the outcome measurements of each study. Each study used a variety of measures; commonly used items were forward elevation (FE, 18 and 5 articles for cemented PEG and modern MBG, respectively), external rotation (ER, 18 and 5 articles), Constant score (13 and 3 articles), and ASES scores (7 and 6 articles), pain visual analogue scale (VAS, 5 and 7 articles), complications (most articles), and revision surgeries or failure (all articles) (Fig. [5](#Fig5){ref-type="fig"}). The results for each article for each commonly used item are shown in Table [2](#Tab2){ref-type="table"}. Table 1Demographic data and outcome measurement of individual studiesAuthorsLevel of EvidenceDesignCasesMean age (y, range)Mean FU (m, range)Range of motionOutcome measurementsCemented all-polyethylene glenoid components (PEG) Raiss (2008)IVAequalis^a^2155 (37--60)7 years (5--9)FE, ABD, IR, ERConstant score Rice (2008)IVCofield II^b^1466 (52--78)5 years (2--8)ABD, ERNeer result rating Fox (2009)IVMixed^c^97266.468.1NN Edwards (2010)IAequalis^a^4769 ± 1126 (12--38)NN Throckmorton (2010)IIICofield10068.6 (52--80)48.5 (24--98)FE, IR, ERVAS Arnold (2011)IVGlobal Advantage^d^3570 (49--89)43 (24--66)NConstant score Collin (2011)IIAequalis^a^5666.7 (43--83)120 (102--155)NN Walch (2011)IVAequalis^a^33369.3 (35--90)89.5 (61--152)FE, ERConstant score Young (2011)IVAequalis^a^22666.9 (40--90)122.7 (61--219)FE, ERConstant score Raiss (2012)IVAequalis^a^3964 (43--79)132 (120--180)FE, ABD, IR, ERConstant score Wirth (2012)IVGlobal Advantage^d^4466 (52--79)48 (24--84)FE, IR, ERVAS, ASES score, SST Denard (2013)IVAequalis^a^5050.5 (35--55)115.5 (60--211)FE, ERConstant score Greiner (2013)IVAffinis^e^9766.6 (30--85)58.8 (31.2--92.5)FE, ABDConstant score Raiss (2014)IVN (mixed)329N8.0 years (4--17)FE, ERConstant score Gazielly (2015)IVAequalis^a^3968.1 (51--81)102 (56.4--150)FE, ERConstant score, pain score Gulotta (2015)IIIBioModular^f^4068.2 ± 9.138 (24--45)NVAS, ASES Noyes (2015)IVGlobal Advantage^d^4264 (51--80)80 (63--114)FE, ERASES Wright (2015)IVEquinoxe^g^2466.4 ± 9.129.6 ± 8.7FE, ABD, IR, ERConstant score, ASES, SST, UCLA Parks (2016)IVAffiniti^h^7663.5 (39--86)28.7 (24--60)FE, ABD, IR, ERConstant score, ASES Wijeratna (2016)IVGlobal Advantage^d^8368.6 (49--88)46.7 (24--99)FE, IR, ERASES, Oxford score McLendon (2017)IVCofield II^i^28765 (21--85)84 (48--171.6)NN Service (2017)IIIGlobal Advantage^d^7168 ± 8.330 ± 7.2NSST Gauci (2018)IIIAequalis^a^4655(40--60)123.6 ± 26 (60--144)FE, ERVAS, Constant score, SSV Raiss (2018)IVAequalis^j^11868 (51--85)38 (24--70)NN Sanchez-Sotelo (2018)2018/IVPEG20267 (24--93)32.4 (24--60)FE, IR, ERASESModern design of metal-backed glenoid component (MBG) Castagna (2010)IVSecond-generation SMR^l^3562.7 (55.3--70.1)75.4NVAS, Constant score, SST Fucentese (2010)IVSulmesh^m^2268.5 (49--84)50 (24--89)NConstant score Budge (2013)IVTantalum TM^n^1962.8 ± 14.631 (24--64)ERVAS, ASES score Styron (2016)IVTantalum TM^n^6666.2 (31--88)50.2FE, IR, ERN Sandow (2016)IVTantalum TM^n^10(60--79)24FEVAS, Oxford score, ASES score Panti (2016)IVTantalum TM^n^7669.6 (52--81)43.2 (24--72)FE, ABD, ERVAS, ASES score Endrizzi (2016)IVTantalum TM^n^7367.5 ± 8.6 (46--85)50.8 (24--68)NVAS, ASES score Merolla (2016)IVTantalum TM^n^4063.8 (40--75)38 (24--42)FE, ABD, ERHealth state, Constant score, ASES score Gurin (2017)IVTantalum TM^n^80N100NVAS Watson (2018)IVTantalum TM^n^3666.36 (50--85)34.1 (23--61)FE, ERVAS, SANE score, Penn score, ASES scoreCommon outcome measurementsRadiolucency, loosening, complication, and revision surgery (failure)*N* not recorded, *y* year, *m* month, *FU* follow-up, *FE* forward elevation, *ABD* abduction, *IR* internal rotation, *ER* external rotation, *VAS* visual analogue scale, *ASES* American shoulder and elbow surgeons, *SST* simple shoulder test, *SF*-12 short form-12, *UCLA* University of California at Los Angeles, *SSV* subjective shoulder value, *SANE* single alpha-numeric evaluation^a^Unconstrained, cemented, third-generation implant (Aequalis Primary Shoulder Prosthesis; Tornier Inc., Edina, Minnesota, USA) or Aequalis prosthesis (Tornier, Mont Bonnot, France)^b^Cofield 2 keeled all-polyethylene cemented components with a posterior augmentation (Smith and Nephew, Inc., Memphis, TN, USA)^c^Neer II all-polyethylene components (3 M, St. Paul, MN; Kirschner Medical Corporation, Fairlawn, NJ; Biomet, Warsaw, IN, USA), Cofield 1 all-polyethylene component, Cofield 2 all-polyethylene keeled, and Cofield 2 all-polyethylene pegged components (Smith & Nephew, Memphis, TN, USA)^d^Depuy Global Advantage with an Anchor Peg glenoid (Depuy, Warsaw, IN, USA)^e^Affinis shoulder prosthesis (Mathys Ltd. Bettlach, Switzerland)^f^BioModular Total Shoulder System with an all-polyethylene, cemented, pegged glenoid (Biomet, Inc., Warsaw, IN, USA)^g^Equinoxe (Exactech, Inc., Gainesville, FL, USA)^h^Affiniti CortiLoc glenoid (Tornier, Inc., Edina, MN, USA)^i^Cofield II all-polyethylene pegged component (Smith & Nephew, Memphis, TN, USA)j Cemented keeled glenoid with different backside radiuses of curvature (Tornier/Wright Medical, Memphis, TN, USA)^k^ReUnion (Stryker, Mahwah, NJ, USA)^l^Second generation SMR System (Lima Corporate, Villanova, Italy)^m^Titanium metal-backed glenoid component (Sulmesh; Zimmer, Winterthur, Switzerland)^n^Second-generation porous tantalum trabecular metal glenoid (Zimmer, Warsaw, IN, USA) Fig. 5Distribution of outcome measurements. FE, forward elevation; ABD, abduction; IR, internal rotation; ER, external rotation; ASES, American shoulder and elbow surgeons; VAS, visual analogue scale; SST, simple shoulder test; SSV, subjective shoulder value; SF-12, short form-12; UCLA, University of California at Los Angeles; SANE, single alpha-numeric evaluation Table 2Clinical outcomes of individual studiesAuthorsCasesGain of FE (°)Gain of ER (°)RadiolucencyLooseningRevision surgeriesOther reoperationsCemented all-polyethylene glenoid components (PEG) Raiss (2008)2150.728.110 (48%)1000 Rice (2008)14N211 (7%)100 Fox (2009)972NNN15260 Edwards (2010)47NNN020 Throckmorton (2010)10048.328.6N1000 Arnold (2011)35NN5000 Collin (2011)56NNN2032: RC repair Walch (2011)33351.726.3965753: open contracture release Young (2011)22639.723.314499372: Periprosthetic fracture3: instability2: RC repair2: infection2: stiffness Raiss (2012)394924NN10 Wirth (2012)44141.934.6NN10 Denard (2013)50312130 of 4821 of 48170 Greiner (2013)9759.6N9370 Raiss (2014)25046.925.0N100220 Gazielly (2015)3942.425.78610 Gulotta (2015)40NNN001 infection1 biceps tendinitis Noyes (2015)423078N10 Wright (2015)2444.224.85 of 15000 Parks (2016)7631131417 of 80N Wijeratna (2016)83NN5113 contracture release1: RC repair1: capsular plication McLendon (2017)287NNN120360 Service (2017)71NN19130 Gauci (2018)464026N1010N Raiss (2018)118NNN020 Sanchez-Sotelo (2018)202NN0072Modern design of metal-backed glenoid component (MBG) Castagna (2010)35NN8 (22%)000 Fucentese (2010)22NNN3 (14%)3 (14%)0 Budge (2013)19N447 (37%)4 (21%)3 (16%)N Styron (2016)667036N13 of 58 (23%)1 (2%)N Sandow (2016)10NN0000 Panti (2016)7654.440.85 (7%)001: RC repair Endrizzi (2016)73NN24 of 66 (36.4%)1 of 66 (1.5%)1 (1%)0 Merolla (2016)40NN2 (5%)000 Gurin (2017)80NNN02 (3%)0 Watson (2018)36NN1 (2.8%)1 (2.8%)1 (3%)N*N* not recorded, *FE* forward elevation, *ER* external rotation, *RC* rotator cuff

Clinical outcomes and complications of cemented PEG and modern MBG groups {#Sec11}
-------------------------------------------------------------------------

Based on the data obtained in Table [2](#Tab2){ref-type="table"}, an overall comparison between the two groups was performed (Table [3](#Tab3){ref-type="table"}). The mean gain of the arc of flexion-extension (F-E) was 48.6° and 61.7° and the ER increase was 24.2° and 39.2°, the mean Constant score increase was 34.8 and 40.4, and the ASES score was 44.5 and 56.5 for cemented PEG and modern MBG, respectively (Fig. [6](#Fig6){ref-type="fig"}). Rates of radiolucent lines, loosening, and revision surgery were lower in the modern MBG group, although incomplete results did not resolve heterogeneity. The causes of the revision are summarized in Fig. [7](#Fig7){ref-type="fig"}; the most common cause of reoperation for the cemented PEG group was loosening of glenoids (83 out of 141 known causes, 59.0%), and fractures of glenoid components for the modern MBG group (6 out of 11 known causes, 54.5%). Table 3Summary of cemented PEG and modern MBGCemented PEG (*n* = 3312)Modern MBG (*n* = 457)*P*--valueAge (years)Number of cases/articles3062/24367/8NA**Mean66.4 (21--93)66.5 (31--88)**Follow--up duration (months)Number of cases/articles3312/25457/10NA**Mean73.1 (12--211)56.1**Gain of FE (°)Number of cases/articles1387/14142/2NA**Mean48.661.7**Gain of ER (°)Number of cases/articles1304/14161/3NA**Mean24.239.2**Constant score improvementNumber of cases/articles1208/93/97NA**Mean34.840.4**ASES score improvementNumber of cases/articles226/5135/3NA**Mean44.556.5**Primary osteoarthritis**Yes (%)2866 (86.5%)350 (88.4%)**0.310No (%)446 (13.5%)46 (11.6%)Diagnosis unknown161Radiolucent lines**Present (%)354 (27.2%)22 (4.9%)**NAAbsent (%)948 (72.8%)427 (95.1%)Not reported20108Loosening**Present (%)465 (14.6%)22 (4.9%)**NAAbsent (%)2720 (85.4%)427 (95.1%)Not reported1278Revision surgery**Present (%)189 (5.7%)11 (2.4%)**NAAbsent (%)3127 (94.3%)446 (97.6%)Not reported00*PEG* all-polyethylene glenoid, *MBG* metal-backed glenoid, *NA* not applicable, *FE* forward elevation, *ER* external rotation, *ASES* American shoulder and elbow surgeons Fig. 6Graph showing the distribution of preoperative and postoperative clinical scores for each article. ASES, American shoulder and elbow surgeons Fig. 7Graph showing the causes of revisions. PEG, polyethylene glenoid; MBG, metal-backed glenoid; Fx., fracture

Scatter plots and subgroup analysis according to the FU duration {#Sec12}
----------------------------------------------------------------

We performed additional scatter plot and subgroup analyses according to the FU duration, which showed a heterogeneous pattern. The trend lines showed that the MBG group tended to have lower loosening and revision rates than the PEG group over time (Fig. [8](#Fig8){ref-type="fig"}a and b). Table [4](#Tab4){ref-type="table"} shows the results of subgroup analysis according to the FU period. The results of \< 36-month and 36--72-month subgroups showed that cemented PEG showed good results in terms of radiolucency and loosening, but that there was no significant difference in failure rate (*P* = 0.754 and 0.829 for \< 36-month and 36--72-month subgroups). In contrast, in \> 72-month subgroup, modern MBG showed better results in terms of loosening (*P* \< 0.001) and revision rates (*P* = 0.006). We additionally compared two groups, after excluding three studies which included only young adults \[[@CR14], [@CR17], [@CR24]\]. The scatter plot analysis and subgroup analysis according to the FU duration showed the same trend as that of the main analysis (Table [5](#Tab5){ref-type="table"}, Fig. [9](#Fig9){ref-type="fig"}a and Fig. [9](#Fig9){ref-type="fig"}b). Fig. 8(**a**) Scatter plots showing the loosening rates for each study. **b** Scatter plots showing the revision rates for each study. PEG, polyethylene glenoid; MBG, metal-backed glenoid; Vertical dotted lines, thresholds (3 and 6 years) for dividing \< 36-month, 36--72-month, and \> 72-month subgroups; Black line, the trendline of modern metal-backed glenoid group; Red line, trendline of cemented polyethylene glenoid group Table 4Subgroup analysis according to the follow-up durationItems\<36-month subgroup^a^36--72-month subgroup^b^\>72-month subgroup^c^PEGMBGPEGMBGPEGMBGAge (years)66.764.866.967.365.362.7Number of radiolucency (%)38/439 (7.3%)8/65 (12.3%)20/229 (8.7%)31/182 (17.0%)296/709 (41.7%)8/35 (22.9%)*P* = 0.355***P*** **= 0.015 \**P*** **= 0.033 \***Number of loosening2/420 (0.5%)5/65 (7.7%)19/1459 (1.3%)17/269 (6.3%)443/1306 (33.9%)0/115 (0%)***P*** **\< 0.001 \**P*** **\< 0.001 \**P*** **\< 0.001 \***Number of failure (=revision)19/424 (4.5%)4/65 (6.2%)37/1503 (2.5%)5/277 (1.8%)133/1389 (9.6%)2/115 (1.7%)*P* = 0.754*P* = 0.829***P*** **= 0.002 \****FU* follow-up, *PEG* cemented all-polyethylene glenoid, *MBG* metal-backed glenoid^a^follow-up duration less than 36 months^b^follow-up duration between 36 and 72 months^c^follow-up duration more than 72 months\*statistically significant change Table 5Subgroup analysis except for 3 articles which included only young adultsItems\<36-month subgroup^a^36--72-month subgroup^b^\> 72-month subgroup^c^PEGMBGPEGMBGPEGMBGAge (years)66.764.866.967.366.762.7Number of radiolucency (%)38/439 (7.3%)8/65 (12.3%)20/229 (8.7%)31/182 (17.0%)256/640 (40.0%)8/35 (22.9%)*P* = 0.355***P*** **= 0.015 \**P*** **= 0.05**Number of loosening2/420 (0.5%)5/65 (7.7%)19/1459 (1.3%)17/269 (6.3%)402/1191 (33.8%)0/115 (0%)***P*** **\< 0.001 \**P*** **\< 0.001 \**P*** **\< 0.001 \***Number of failure (=revision)19/424 (4.5%)4/65 (6.2%)37/1503 (2.5%)5/277 (1.8%)106/1272 (8.3%)2/115 (1.7%)*P* = 0.754*P* = 0.829***P*** **= 0.006 \****FU* follow-up, *PEG* cemented all-polyethylene glenoid, *MBG* metal-backed glenoid^a^follow-up duration less than 36 months^b^follow-up duration between 36 and 72 months^c^follow-up duration more than 72 months\*statistically significant change Fig. 9(**a**) Scatter plots showing the loosening rates for each study excluding three studies which included only young adults (**b**) Scatter plots showing the revision rates for each study excluding three studies which included only young adults. PEG, polyethylene glenoid; MBG, metal-backed glenoid; Vertical dotted lines, thresholds (3 and 6 years) for dividing \<36-month, 36--72-month, and \> 72-month subgroups; Black line, trendline of modern metal-backed glenoid group; Red line, trendline of cemented polyethylene glenoid group

Discussion {#Sec13}
==========

Although failure rates did not differ significantly between the two glenoid types in \< 36-month and 36--72-month subgroups, modern MBGs were found to have lower radiolucency, loosening, and failure rates than cemented PEG in \> 72-month subgroup (*P* = 0.033, \< 0.001, and 0.006, respectively). This is in line with the results obtained from the scatter plot analysis. Also, the gains of FE and ER, Constant score, and ASES score of the modern MBG group were not lower than those of cemented PEG. Taken together, these results show that the modern MBG is comparable to the cemented PEG, with promisingly better results in a few of these aspects.

The trends in outcomes were found to differ between the two groups as the FU duration increased. In the cemented PEG group, loosening and failure rate typically increased as the FU duration increased. In contrast, \> 72-month subgroup was comparable to \< 36-month subgroup in the modern MBG group. This may be because it is possible that the MBG was stably fixed, and that bony ingrowth was sufficient. If the modern MBG design caused stable fixation and bony ingrowth as the design originally intended, it makes sense that there were some initial failures in the modern MBG group and that the results of \> 72-month subgroup of the modern MBG were better than PEG. Moreover, it is possible that the error occurred due to the lack of studies with a long-term FU on modern MBGs. In order to confirm this conclusion, more long-term FU studies on modern MBGs should be performed.

A previous systematic review by Papadonikolakis and Matsen compared rates of complications and revision surgeries between MBG and PEG. They included all designs of MBGs up to 2013 in the same group and reported that MBGs showed significantly higher revision rates than PEG \[[@CR3]\]. Categorical data such as loosening and revision were analyzed by crosstab analysis as in this study. The review is a well-performed study that has served as a reference for the selection of glenoid components. We tried to increase the credibility of the analytical results by conducting heterogeneity assessments and adjustments that did not appear to be performed in the previous review.

The MBG was designed to induce bone ingrowth using the porous-coated component on the glenoid contact surface, and smooth ROM on the joint surface using the PE component. Because of this, they were expected to be the ideal component. However, the results of clinical studies using the conventional MBG design were disappointing \[[@CR2], [@CR16], [@CR17], [@CR44]--[@CR51]\]. These failures were caused by several factors. First, MBG failure is often associated with PE wear, which is often caused by thinner PE thickness in these designs due to the metal back \[[@CR16]\]. Second, overstuffing of joints can be induced to ensure sufficient PE thickness, resulting in loosening and rotator cuff tears, which ultimately leads to joint instability. Third, breakages of rods and screws may occur that are not caused by cemented PEG.

Attempts have been made to improve this by modifications to the MBG's design. Second-Generation SMR MBG (SMR System, Lima Corporate, Villanova, di San Daniele, Udine, Italy) is the representative of this modern design. Castagna and Garofalo reported good results using this instrument, due to the curved-backed and less conforming shape of the glenoid, the stiff and thick metal back (5 mm) for reducing stress and wear on the PE component, applying hydroxyapatite to pegs as well as the baseplate, and initial strong fixation using two screws and one central peg \[[@CR4]\]. Other representative modern designs are Zimmer's trabecular porous tantalum and titanium TM. The first generation of TM, the Sulmesh, consists of several titanium meshes, with four pegs protecting the metal back. The second-generation TM shows an improved design with porous tantalum keels. Recently, many clinical studies on these modern designs of MBG have been reported, and with the exception of a few studies, good results were reported with low failure rates and fast bony ingrowth around keels \[[@CR4]--[@CR6], [@CR37]--[@CR43], [@CR52]\].

A study by Page et al. on similar topics analyzed glenoid revision rates using the Australian Orthopaedic Association National Joint Replacement Registry, which began in 2004. Cementless MBG was classified into modular type and fixed type in the study. Among them, SMR L2 and TM glenoid which were considered as modern design in this review were included in the analysis. Cementless glenoids showed a significantly higher revision rate than cemented glenoids \[[@CR53]\]. Contrary to the results presented by Castagna et al. \[[@CR4]\], The SMR L2 design showed higher revision rate than other designs. Based on the result, SMR L2 was withdrawn from the market in Austrailia. TM glenoids, on the other hand, showed the same low revision rate in this review and the study by Page et al. \[[@CR53]\]. Results of this review and the study by Page et al. suggest that surgeons should be cautious in MBG selection because it can produce different results for different designs. Among MBG designs, TM glenoids are most promising and comparable to cemented glenoids.

This study has several limitations. First, there is no clear global consensus on the distinction between modern design and conventional design. However, a rationale was found through a review article on glenoid components by Castagna and Garofalo \[[@CR10]\] and three models were defined as modern designs. Second, there is the possibility of remaining heterogeneity between studies. We thoroughly discussed this point at the research design stage and conducted data analysis and pooling after sufficient distribution analysis and adjustment of bias. Third, studies use different criteria for the definition of radiolucency and loosening in the main outcomes. Here, these were summarized using the most common and objective items as was possible, and credibility was increased by eliminating ambiguous data. Ultimately, the most objective and ultimate outcome indicator is failure or revision rate, and the failure rate results presented in this review suggest that modern MBG is promising. Fourth, cemented PEGs were not divided into conventional and modern designs. Cemented PEGs have long been the standard glenoid designs for TSA, showing relatively consistent results and trends. Thus, we could not clearly classify them into modern and conventional designs.

The fifth limitation is the lack of longer-term FU data across all implants. It is especially true in the modern MBG group, leading to the shortened criteria for dividing subgroups (36 and 72 months). This is because many surgeons still prefer cemented PEGs, and the modern designs of MBGs are still quite new. Since new designs are being developed in addition to the modern MBGs included in this study, a definite consensus on MBGs may be formed if more long-term FU studies on the MBGs as well as cemented PEGs are actively conducted.

Conclusion {#Sec14}
==========

The modern MBG component, especially TM glenoid, seems to be a promising alternative to cemented PEGs, based on subgroup revision rates according to the follow-up duration and overall results of ROM and clinical scores. All polyethylene glenoids tend to increase loosening and failure over time. The modern MBG seems to have no difference in failure, at least in the \< 36-month and 36--72-month subgroups compared to the cemented PEG. More long-term follow-up studies on modern MBG should be ultimately conducted.

ASES

:   American shoulder and elbow surgeons

ER

:   external rotation

F-E

:   flexion-extension

FE

:   forward elevation

FU

:   follow up

MBG

:   metal-backed glenoid

MINORS

:   methodological index for non-randomized studies

N

:   not recorded

PE

:   polyethylene

PEG

:   cemented polyethylene glenoid

RC

:   rotator cuff

ROM

:   range of motion

TM

:   trabecular metal

TSA

:   total shoulder arthroplasty

VAS

:   visual analogue scale
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